SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-061344
Filing Date
2022-03-01
Accepted
2022-03-01 16:17:11
Documents
16
Period of Report
2022-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d258445d8k.htm   iXBRL 8-K 28043
2 EX-99.1 d258445dex991.htm EX-99.1 161679
7 GRAPHIC g258445g0228085456295.jpg GRAPHIC 3240
8 GRAPHIC g258445g0228085456577.jpg GRAPHIC 2807
  Complete submission text file 0001193125-22-061344.txt   385863

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zlab-20220301.xsd EX-101.SCH 3899
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zlab-20220301_def.xml EX-101.DEF 14101
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zlab-20220301_lab.xml EX-101.LAB 23454
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zlab-20220301_pre.xml EX-101.PRE 15128
10 EXTRACTED XBRL INSTANCE DOCUMENT d258445d8k_htm.xml XML 5708
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38205 | Film No.: 22698259
SIC: 2834 Pharmaceutical Preparations